I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests No Clinical Benefit with Addition of Nebulized ZYESAMI® (aviptadil) When Given by Mouth Inhalation in Critically Ill P...

SAN FRANCISCO, March 31, 2022 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC) announced in collaboration with NRx Pharmaceuticals, In...

Related Keywords

California ,United States ,San Francisco , ,University Of California ,National Institutes Of Health ,World Health Organization ,Drug Administration ,Data Monitoring Committee ,Nrx Pharmaceuticals Inc ,Nrx Pharmaceuticals ,Nasdaq ,Nrxp Nrx Pharmaceuticals ,Us National Institutes Of Health ,Quantum Leap Healthcare Collaborative ,Human Vasoactive Intestinal Polypeptide ,National Institutes ,High Flow Nasal Cannula ,Mechanical Ventilation ,Silicon Valley ,Fast Track ,Breakthrough Therapy ,Special Protocol Agreement ,Biomarker Letter ,Serial Studies ,Predict Your ,Biomarker Integration ,Adaptive Learning ,Quantum Leap Healthcare ,Leap Healthcare ,